174 related articles for article (PubMed ID: 10716982)
1. Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes.
O'Brien T; Tjian R
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2456-61. PubMed ID: 10716982
[TBL] [Abstract][Full Text] [Related]
2. The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.
Suzuki-Yagawa Y; Guermah M; Roeder RG
Mol Cell Biol; 1997 Jun; 17(6):3284-94. PubMed ID: 9154827
[TBL] [Abstract][Full Text] [Related]
3. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.
Wang EH; Zou S; Tjian R
Genes Dev; 1997 Oct; 11(20):2658-69. PubMed ID: 9334328
[TBL] [Abstract][Full Text] [Related]
4. Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.
Dunphy EL; Johnson T; Auerbach SS; Wang EH
Mol Cell Biol; 2000 Feb; 20(4):1134-9. PubMed ID: 10648598
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus 1 late gene expression is preferentially inhibited during infection of the TAF250 mutant ts13 cell line.
Dhar S; Weir JP
Virology; 2000 Apr; 270(1):190-200. PubMed ID: 10772991
[TBL] [Abstract][Full Text] [Related]
6. TATA-binding protein-free TAF-containing complex (TFTC) and p300 are both required for efficient transcriptional activation.
Hardy S; Brand M; Mittler G; Yanagisawa J; Kato S; Meisterernst M; Tora L
J Biol Chem; 2002 Sep; 277(36):32875-82. PubMed ID: 12107188
[TBL] [Abstract][Full Text] [Related]
7. CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.
Vargas GA; Isas JM; Fantino E; Gargus JJ; Haigler HT
J Cell Physiol; 1998 Sep; 176(3):642-7. PubMed ID: 9699517
[TBL] [Abstract][Full Text] [Related]
8. TAF(II)250-independent transcription can be conferred on a TAF(II)250-dependent basal promoter by upstream activators.
Weissman JD; Howcroft TK; Singer DS
J Biol Chem; 2000 Apr; 275(14):10160-7. PubMed ID: 10744699
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the human TAFII250 N-terminal kinase domain.
O'Brien T; Tjian R
Mol Cell; 1998 May; 1(6):905-11. PubMed ID: 9660973
[TBL] [Abstract][Full Text] [Related]
10. Extensive interactions between HIV TAT and TAF(II)250.
Weissman JD; Hwang JR; Singer DS
Biochim Biophys Acta; 2001 Mar; 1546(1):156-63. PubMed ID: 11257518
[TBL] [Abstract][Full Text] [Related]
11. Distinct mutations in yeast TAF(II)25 differentially affect the composition of TFIID and SAGA complexes as well as global gene expression patterns.
Kirschner DB; vom Baur E; Thibault C; Sanders SL; Gangloff YG; Davidson I; Weil PA; Tora L
Mol Cell Biol; 2002 May; 22(9):3178-93. PubMed ID: 11940675
[TBL] [Abstract][Full Text] [Related]
12. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250.
Wang EH; Tjian R
Science; 1994 Feb; 263(5148):811-4. PubMed ID: 8303298
[TBL] [Abstract][Full Text] [Related]
13. Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression.
Howcroft TK; Raval A; Weissman JD; Gegonne A; Singer DS
Mol Cell Biol; 2003 May; 23(10):3377-91. PubMed ID: 12724398
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription.
Guermah M; Tao Y; Roeder RG
Mol Cell Biol; 2001 Oct; 21(20):6882-94. PubMed ID: 11564872
[TBL] [Abstract][Full Text] [Related]
15. Transactivation mediated by B-Myb is dependent on TAF(II)250.
Bartusel T; Klempnauer KH
Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
[TBL] [Abstract][Full Text] [Related]
16. TAFII55 binding to TAFII250 inhibits its acetyltransferase activity.
Gegonne A; Weissman JD; Singer DS
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12432-7. PubMed ID: 11592977
[TBL] [Abstract][Full Text] [Related]
17. TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74.
Dikstein R; Ruppert S; Tjian R
Cell; 1996 Mar; 84(5):781-90. PubMed ID: 8625415
[TBL] [Abstract][Full Text] [Related]
18. TAF-like functions of human cytomegalovirus immediate-early proteins.
Lukac DM; Harel NY; Tanese N; Alwine JC
J Virol; 1997 Oct; 71(10):7227-39. PubMed ID: 9311796
[TBL] [Abstract][Full Text] [Related]
19. DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator.
Chalkley GE; Verrijzer CP
EMBO J; 1999 Sep; 18(17):4835-45. PubMed ID: 10469661
[TBL] [Abstract][Full Text] [Related]
20. TAF(II)170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity.
Pereira LA; van der Knaap JA; van den Boom V; van den Heuvel FA; Timmers HT
Mol Cell Biol; 2001 Nov; 21(21):7523-34. PubMed ID: 11585931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
